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Background: Despite detailed knowledge about the structure and signaling properties of individual collagen
receptors, much remains to be learned about how these receptors participate in linking cells to ﬁbrillar collagen
matrices in tissues. In addition to collagen-binding integrins, a group of proteinswith afﬁnity both forﬁbrillar col-
lagens and integrins link these two protein families together. We have introduced the name COLINBRI (COLlagen
INtegrin BRIdging) for this set of molecules. Whereas collagens are the major building blocks in tissues and de-
fects in these structural proteins have severe consequences for tissue integrity, the mild phenotypes of the
integrin type of collagen receptors have raised questions about their importance in tissue biology and pathology.
Scope of review: We will discuss the two types of cell linkages to ﬁbrillar collagen (direct- versus indirect
COLINBRI-mediated) and discuss how the parallel existence of direct and indirect linkages to collagens may
ensure tissue integrity.
Major conclusions: The observedmild phenotypes ofmice deﬁcient in collagen-binding integrins and the relative-
ly restricted availability of integrin-binding sequences inmature ﬁbrillar collagenmatrices support the existence
of indirect collagen-binding mechanisms in parallel with direct collagen binding in vivo.
General signiﬁcance: A continued focus on understanding the molecular details of cell adhesion mechanisms to
collagens will be important and will beneﬁt our understanding of diseases like tissue- and tumor ﬁbrosis
where collagen dynamics are disturbed. This article is part of a Special Issue entitled Matrix-mediated cell
behaviour and properties.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The view of the extracellular matrix (ECM) has changed dramatical-
ly in the past three decades. From being regarded as merely a structural
framework where cell–cell contacts were thought to be the main orga-
nizers of functional organ units, the ECM is taking more and more of a
centre stage in modern cell biology. We know today that the ECM in
addition to functioning as a structural framework has many other
roles including: acting as storage depots for growth factors and cyto-
kines [1,2], regulating stem cell fate [3], elaborating stem cell niches
[4] and thus affecting many aspects of a cell's life. Still, a major role of
the ECM is to act as tissue glue. On the anecdotal side, the word “colla-
gen” itself derives from the Greek κόλλα/kolla, “glue”, from the practiceM, extracellular matrix; EMT,
X, lysyl oxidase; M4/5, mono-
stin; SLRP, small leucine-rich
in; vWF, von Willebrand factor
-mediated cell behaviour and
ullberg).
. Open access under CC BY-NC-ND licof boiling animal skins in ancient times to make glue. In the current re-
view we will mainly discuss collagens as molecular glue when present
in the body as native collagen ﬁbrils.
Collagens are themost abundant proteins in vertebrate organisms. Al-
though composed of 28 different proteins [5], a few family members (i.e.
collagens I–III) of the ﬁbrillar collagens (collagens I, II, III, V, XI, XXIV and
XXVII) [6] dominate quantitatively and form the framework of connective
tissues in the bone, cartilage, tendons and soft interstitial matrices.
The starting point for the changed view of the matrix (not just a
structural component but a dynamic regulatory compartment in
tissues) was the identiﬁcation of matrix receptors [7,8]. In recent
years, our knowledge of how these receptors signal and cross-talk
with other receptor groups has increased. A major group of receptors
for collagens are found in the integrin family [7,9,10]. In addition to
collagen-binding integrins, syndecans, discoidin domain receptors
(DDRs), GpVI, LAIR [9], OSCAR [11] and GPR56 [12] have been implied
to be collagen receptors. Interestingly, recent data suggest that DDRs
can act by activating collagen-binding integrins [13–15], while blocking
DDR–collagen interaction leads to reduced integrin-mediated cell
adhesion.
Most of the detailed knowledge about how integrins and other
receptors work has been collected from experiments performed withense.
Fig. 1. Schematic illustration of direct (collagen-binding integrin-mediated) and indirect
(COLINBRI-mediated) binding to collagen ﬁbrils. In the direct cell-binding mechanism,
collagen-binding integrins (brown) directly interact with the ﬁbrillar collagen (green)
through theirαI domain to provide cell adhesion. In the indirectway, cell binding involves
COLINBRIs like ﬁbronectin (purple) represented here. The COLINBRI molecule is anchored
to collagen and provides cell attachment by interaction with the COLINBRI-binding
integrins (magenta), which are lacking αI domain.
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molecular composition of the actual linkages in the tissues; from the
cell attachment points to the ECM based ﬁbrils and networks (tissue
glue function). We will discuss how ﬁbrillar collagen is arranged in
the tissues and how cells stick to ﬁbrillar collagenmatrices; direct bind-
ing via collagen receptors and indirect binding via bridging molecules.
We use the name “COLINBRI” (COLlagen INtegrin BRIdging) for a class
of non-collagen molecules with the potential to bridge the binding of
integrins to ﬁbrillar collagens [16].
2. Collagen
Collagens come in many different forms and in the current review
we will focus on the interaction of connective tissue cells with the
major ﬁbrillar collagens. Collagens have as a major function to serve as
a structural scaffold in forming tissues—being the mold onto which tis-
sues grow. In normal adult tissues, collagens fulﬁll the function of main-
taining tissue structure, but during ﬁbrosis, excess collagen synthesis
may cause tissue dysfunction. Since ﬁbrillar collagens are large mole-
cules existing in complex environments, they also have the capacity to
interact with secreted proteins in themicroenvironment, which can im-
pose a greater adhesivity to the matrix scaffold. This alloy of collagen –
COLINBRIS – and cell receptors constitute the components of thismolec-
ular tissue glue.
The mechanical properties of this molecular glue can be changed
either by crosslinking of collagen ﬁbrils, or by crosslinking of secreted
proteins onto the ﬁbrillar collagenmatrix, thereby changing the stiffness
of the collagen-based matrix. Accordingly, this will change the ability of
cells to respond to the collagen-based tissue glue. Lysyl oxidases (LOX)
are important enzymes in this regard. Periostin (PN) is an interesting
matricellular ECMmolecule and COLINBRI has been suggested to change
the stiffness of the collagenmatrix [17,18]. Transglutaminases are anoth-
er group of molecules with the potential to change the properties of
matrix proteins, including collagens [19]. Furthermore, the composition
of proteoglycan (PG) protein cores and their glycosaminoglycan chains
affects matrix stiffness, as does age and diabetes associated non-
speciﬁc crosslinking [20–22].
In cancer cells, the term tensional homeostasis has been introduced
to describe the intense relationship between intracellular tension and
extracellular tension, but this term can also be applied to normal cells
in interstitial matrices, and we predict that in years to come, the impor-
tance of tissue stiffness for cell function will be increasingly recognized
[23–25].
Since collagens are major building blocks, one would expect that a
major function of receptors that directly link cells to collagen would
be to maintain the structural integrity of the tissues. On the other
hand, proteins bound to the collagen network might impose additional
functions to the ECM that are not related to the structural integrity, and
thus add functional ﬂexibility. Intriguingly, analyses of mutant mice
lacking integrin type collagen receptors have failed to replicate the se-
vere effects that are seen when ﬁbrillar collagens are mutated or absent
inmice.Wewill later discuss the possible explanations for this anomaly
and speculate on how our picture of collagen receptors might change in
the future.
3. COLINBRIs and COLINBRI-mediated cell binding
WedeﬁneCOLINBRIs asmolecules that form a bridge between ﬁbril-
lar collagens and integrins on cell surfaces. In this reviewwewill list and
discuss someprototypical ECMproteins that could act as COLINBRIs, but
we make no claims to report a complete list of COLINBRIs. We will thus
focus on three relatively abundant, well-characterized proteins that
have the greatest potential to serve as intermediary linkers in the indi-
rect collagen–cell interactions: ﬁbronectin, vitronectin and periostin.
Wewill also brieﬂymention vonWillebrand factor as a COLINBRI of spe-
cial importance for platelets. A schematic illustration of the indirect anddirect binding to collagenﬁbrils is shown in Fig. 1. Thedomain structure,
the collagen-binding sites and the integrin-recognizing sites of three
prototypical COLINBRIs are shown in Fig. 2.
3.1. Fibronectin
Fibronectin (FN) is a ubiquitous extracellular matrix glycoprotein
that promotes cell adhesion, cell migration and cell differentiation
[26]. Mouse embryos lacking FN die at E8.5, presenting a severe failure
in vascular development [27]. FN harbors multiple adhesion sites for
other molecules in the microenvironment including proteoglycans,
TGF-β and collagens [28].
The collagen-binding domain was the ﬁrst FN domain to be isolated
[29]. The domain is located near the N-terminus and is composed of the
repeats 6FNI1–2FNII7–9FNI [30]. Blocking of the collagen-binding domain
demonstrated a role of the FN–collagen interaction in collagenorganiza-
tion anddeposition [31]. FNbinds to bothnative and denatured collagen
(gelatin), but it presents greater afﬁnity for gelatin in vitro [32], suggest-
ing that the FN–collagen interaction occurs with higher afﬁnity in re-
modeling processes like wound repair and tissue growth. In collagen I
the FN-binding site overlaps with the matrix metalloproteinase
(MMP)-1 cleavage site, which has been reported to “breathe” and local-
ly melt, which hence enables FN binding under some conditions [33].
So far, 11 integrin heterodimers, including all members of the αv
subfamily, have been reported to interact with FN (for reviews, see
[34,35]). The recognition of the Arg-Gly-Asp (RGD) motif located in
the 10FNIII domain [36] is central for cell adhesion although other se-
quences are also involved in this interaction [37–39]. The prototypical
“FN receptor” – integrin α5β1 – the ﬁrst integrin to be characterized
[40], is widely expressed on different cell types. Integrin α5-deﬁcient
mice present some similarities with the FN-null mice [41], although
Fig. 2.Collagen- and integrin-binding sites on COLINBRIs. The domain structures of the three COLINBRIs ﬁbronectin (FN), vitronectin (VN) and periostin (PN) are schematized. Fibronectin
is composed of the 1–9I domain (light gray rectangles), the 1–2II domain (light gray ellipses) and the 1–15III domain (dark gray ellipses). The variable spliced domains are represented
in white (EDA/B: extra domain A/B, V: variable). Fibronectin dimerizes through two disulﬁde bonds present at the C-terminal. Fibronectin interacts with collagen via the repeats
6FNI1–2FNII7–9FNI. The RGD sequence is localized in the 10FNIII domain, but other domains are also involved in integrin-mediated cell adhesion. The cell-binding site of vitronectin
(RGDmodule) is located near the somatomedin B domain (SB). Collagen interactionwith vitronectin can bemodulated by itsN-glycosylation (N). Another collagen-binding site is located
in a Hemopexin repeat (HX) in the C-terminal, close to the heparin-binding site (Hp). Collagen I interacts with the EMI domain of periostin, whereas collagen V binds to the Fasciclin 1
domain (FAS1). The binding sites of integrins αvβ3 and αvβ5 are located in the second FAS1 domain whereas the cell-binding site(s) of α6β4 and αMβ2 integrins have not been
characterized.
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binds to the RGD sequence of FN, but high afﬁnity binding for both
integrins are dependent on the synergy site PHSRN located to the
9FNIII [39,42]. The integrins α4β1 and α4β7 interact with the variable
domain of FN through LDV and REDV sequences [37,43]. The α4β1
and α9β1 integrins also both bind to the alternatively spliced extra
domain A (EDA) in FN [44].
The presence of at least one of the alternatively spliced extra domains,
EDA or EDB, is essential during development, since deletion of both re-
gions leads to embryonic lethality [45]. In adult tissues, these FN splice
variants are only expressed at low levels but are upregulated during
wound healing, where the FN-EDA variant is important in the organiza-
tion of the granulation tissue [46]. It has been suggested that FN-EDA is
necessary for TGF-β-induced myoﬁbroblast differentiation [47] and in-
creased levels of FN-EDAhave also been reportedduring tumor angiogen-
esis, epithelial-to-mesenchymal transition (EMT) and ﬁbrosis [48–50].
FN receptor integrins show overlapping functions during embryo-
genesis and FN assembly [51]. Four FN-binding integrins, α4β1, α5β1,
α9β1 andαvβ3, are known to participate in FNassembly. It is important
to recognize that the effects of integrin blockage depend on the total
integrin repertoire. In one study, embryonic cells depleted in either
α5β1 or α4β1 displayed no defects in the FN matrix assembly; this
function is presumably assumedbyαv integrins in these conditions [52],
although other studies have suggested αvβ3-mediated FN assembly to
be less efﬁcient [53]. In a detailed study on the role of FN receptors,
α5-deﬁcient endothelial cells showed reduced FN assembly, whereas
doubleα5/αv-null endothelial cells failed to assemble a FNmatrix alto-
gether, suggesting a cooperation of both integrins in endothelial cell-
mediated FN assembly [54]. In contrast to their overlapping functions
in FN assembly, FN receptor integrins also have distinct roles as support-
ed by the distinct phenotypes of FN receptor deﬁcient mice [41,51].
The ability of FN to bind both ﬁbrillar collagens and multiple RGD-
dependent and RGD-independent integrins, expressed on a variety ofcell types, qualiﬁes FN as a major COLINBRI to have important functions
in a variety of developmental and pathological processes.
3.2. Vitronectin
Vitronectin (VN) is an adhesive glycoprotein present in the blood,
from where it was ﬁrst identiﬁed as the “serum spreading factor” [55],
but it is also present in the ECM [56] and in the α granules of blood
platelets [57]. VN promotes cell adhesion and cell migration and is in-
volved in ﬁbrinolysis, immune defense and hemostasis [58,59]. Initial
studies of VN-deﬁcient mice revealed viable and fertile mice, which
did not display any obvious phenotype comparedwith wild-type litter-
mates [60]. Later studies attributed a role of VN in response to tissue
injury, where VN-null mice displayed delayed wound healing and
decreased angiogenesis [61].
VN is anchored to the ECM via its interaction with collagens and
thus promotes cell adhesion and migration, deﬁning this protein as
COLINBRI. VN interacts with several collagen types, including ﬁbrillar
collagens, but unlike FN, VN shows greater afﬁnity for native triple-
helical collagen [62]. Convincing data have shown that VN can inhibit
FN binding to collagen I, suggesting that these proteins both interact
at a similar site, or sites, on collagen I. Conversely, the collagen-
binding site of VN is located toward the amino terminus, near the cell-
binding site [63]. However, a second binding site has been identiﬁed
toward the carboxy terminus, near the heparin-binding domain of VN
[64]. It is interesting to note that collagen binding of VN can bemodulat-
ed by its glycosylation status [65,66]. Thus, it has been shown that the
presence of N-glycans covalently linked on VN decreases its binding to
collagen, whereas de-N-glycosylation of VN enhances collagen interac-
tion. This suggests that modulating the VN–collagen interaction regu-
lates VN-mediated cell adhesion and migration in the tissues.
Cell interaction with VN is, like FN, mediated via an RGD motif,
which is mapped to the amino terminus of VN. Integrin αvβ3 was the
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as the “VN receptor”, since it at ﬁrst seemed to be speciﬁc to this protein
[67]. In addition to αvβ3, integrins αvβ1, αIIbβ3, αvβ5, αvβ6, and
α8β1 have been described to interact with VN [68–70]. VN can also
induce cell migration and cell signaling, RGD-independently, through
its interaction with the urokinase plasminogen activator receptor [71].
Furthermore, the plasminogen activator inhibitor-1 is known to bind
to the somatomedin B domain of VN, modulating the RGD-dependent
cell interaction [72,73]. Another regulation of the VN–cell interaction
is mediated via the heparin-binding domain, and it has been suggested
that oligomerization of VN in ECM through this domain can enhance
ﬁbroblast adhesion and spreading [74]. The main integrin VN receptor,
αvβ3, is expressed on endothelial cells and plays an important role in
vascular cell biology [75,76]. Since VN is not the only one ligand of
αvβ3, thedifferent biological roles ofαvβ3 are not systematically linked
to the VN functions. However, VN has also been suggested to have roles
in angiogenesis [61], by regulating endothelial function [77] or bymod-
ulating MMP expressions [78].
Although VN-deﬁcient mice display delayed wound healing and VN
is enriched at the sites of injured tissues, the exact role of VN in tissue
repair is not completely clear [61,79]. VN appears to be an important
ECM substrate for epithelial and smooth muscle cell migration in
response to injury, which involves αvβ3 and αvβ5 integrins [80,81].
3.3. Periostin
Initially called osteoblast-speciﬁc factor 2, this member of the
fasciclin I family has been renamed periostin (PN) to reﬂect its high ex-
pression in periosteum and periodontal ligament [82]. PN is expressed
in additional tissues including the bone, heart and skin [83–85]. The
PN null mice show a variable penetrance of a postnatally lethal pheno-
type related to cardiovascular failure. Surviving PN-deﬁcient mice
display dwarﬁsm, defective periodontal ligaments and an incisor erup-
tion defect [86,87]. It is interesting to note that α11 integrin deﬁcient
mice [10] also have a periodontal ligament phenotype, although it is re-
stricted to the incisors. However, direct interaction betweenα11β1 and
PN has not been reported so far and the similar periodontal ligament
phenotypes are presumably more related to their respective collagen
interactions.
PN co-localizes with collagen in vivo and binds directly to collagens I
and V in vitro [88,89]. The type I collagen seems to interact with the EMI
domain of PN [18], whereas collagen V has been found to interact with
the fasciclin-1 domains of PN [89]. Since PN-deﬁcient mice showed al-
tered collagen ﬁbrils, a role of PN in ﬁbrillogenesis has been suggested
[88,90]. During this process, PN has been suggested to act indirectly in
collagen crosslinking by increasing the activation of LOX via interaction
with BMP-1 and FN [91] and to protect against MMP-mediated proteol-
ysis [92]. Other data suggests that a dimeric form of PN could crosslink
collagen ﬁbrils [17].
PN is an adhesive protein that thus promotes cell adhesion and
migration. The integrinsαvβ3 andαvβ5were the ﬁrst candidate PN re-
ceptors to be described, promoting ovarian epithelial tumor cellmotility
[93]. The YHmotif contained in βigH3, a protein structurally close to PN,
was found to be the ligand for both αvβ3 and αvβ5 [94,95]. This motif
located in the second FAS1 domain of PN was later demonstrated as a
cell-binding site [96]. Integrins α6β4 and αMβ2 have also been
described to bind to PN, however for these integrins the cell-binding
sites have not been characterized [97,98].
It has become increasingly clear that PN is involved in tissue repair
and remodeling [99,100]. In wound healing studies, PN-deﬁcient mice
exhibit delayed wound healing [101]. It appears that during wound re-
pair, PN is expressed at day 7 in the granulation tissue and co-localizes
with α-SMA-expressing cells [85]. Furthermore, PN null mice display
reducedα-SMA expression in the granulation tissue, andﬁbroblasts iso-
lated from thesemice present a defect in collagen gel contraction,which
can be rescued by adding recombinant PN. These data demonstrate thatPN is involved in the regulation of myoﬁbroblast differentiation [102]. It
is also interesting to note that PN can be upregulated byTGF-β in dermal
ﬁbroblasts [103]. PN is expressed in the heart, and could contribute to
cardiac development and repair and it has been shown to be upregulat-
ed after vascular injury [104–106]. However, the role of PN in angiogen-
esis seems to be restricted to pathological processes [107,108].
3.4. Von Willebrand factor
VonWillebrand factor (vWF) is amultimeric glycoprotein that plays
a crucial role in hemostasis by promoting platelet adhesion at sites of
vascular injury with high shear stress [109,110]. Collagen binding
occurs via the vWF A1 and A3 domains and the platelet integrin
αIIBβ3 can bind via the RGD sequence in vWF C1 domain [111], qualify-
ing vonWillebrand factor as a COLINBRImolecule for platelets. Deﬁcien-
cy or mutations of vWF lead to von Willebrand disease, a bleeding
disorder [112].
3.5. Matricellular proteins
In addition to PN, which has been described as a matricellular pro-
tein, the matricellular proteins thrombospondins (TSP), SPARC and
osteopontin (for review see [113]) have also the potential to act as
COLINBRIs, since they all directly interact with ﬁbrillar collagens and
with integrins. However, TSP-1, -2 and SPARC are known to induce cel-
lular “de-adhesion” characterized by the loss of focal adhesion and
stress ﬁbers [114], whichwould be in contrast with themolecular tissue
glue concept.
3.6. SLRPs
The small leucine-rich proteoglycan/protein (SLRP) family is com-
posed of 17 ECM proteins that include decorin, biglycan and lumican
[115]. A major role of the SLRPs, determined using SLPR-knockout
mice, is to regulate the collagen ﬁbrillogenesis [116,117]. Recently, it
has been shown that SLRPs can interact with different cell receptors to
regulate cell behavior [118]. Decorin and lumican have been described
to interact with the collagen integrin α2β1, but with low afﬁnity com-
pared to α2β1–collagen I interaction [119,120]. The fact that lumican
increases cell adhesion [121] and strongly inhibits cell migration [122]
could limit its role in some biological processes, but it could act as
COLINBRI in the integrin-based collagen glues.
4. Collagen-binding integrins
Before collagen receptorswere isolated, awidely held belief in the cell
adhesion ﬁeld claimed that cells did not interact directly with collagen,
but via “nectins” [123,124]. From in vitro studies we now know that
cells do interact directly with native collagens via the four collagen-
binding integrins α1β1, α2β1, α10β1 and α11β1 [125]. We will in the
next sections focus on the integrin family and will start our discussion
by summarizingwhat is known about the ligand speciﬁcity of the integrin
type collagen receptors α1β1, α2β1, α10β1 and α11β1 (Table 1).
4.1. Ligand speciﬁcity
Most of the cell adhesion studies have been performed with the
most abundant ﬁbrillar collagens I–III, whereas not so much is known
about the newestmembers of the collagen family. To study direct phys-
iological interactionswith collagens, it is essential to ensure that the col-
lagen used is triple helical and appreciate if the interaction is to be
interpreted within the context of an intact ﬁbril-bundle, ﬁbril, damaged
ﬁbril structure with developing ﬁbers or with collagen monomers.
Interactions with these structures may or may not be analogous. For in-
stance, amature ﬁbril is a structure that by designwould be expected to
be somewhat robust. Structural data has indicated that theﬁbril exterior
Table 1
Ligand speciﬁcity of collagen-binding integrins.
Integrin Recognition of
the ﬁbrillar
form of
collagen
Collagen speciﬁcity Recognition
sequence
speciﬁcity in
monomeric collagen
References
α1β1 No Collagen IV N
collagens I, II,
and III
GFOGER (in coll. I,
II, IV and more)
GVOGEA (in coll. II)
GLOGEN (in coll. III)
[205–207]
Collagen IX ?
Collagen XIII ?
Collagen XVIII ?
α2β1 Yes Collagen I N
collagen IV
GFOGER (in coll. I,
II, IV and more)
GMOGER
[206,207]
[130]
Collagen IX ?
Collagen XXIII
α10β1 No Collagen
IV/VI N collagen II
GFOGER (in coll. I,
II, IV and more)
[173,206,207]
Collagen IX ?
α11β1 Yes Collagen I N
collagen IV
GFOGER (in coll. I,
II, IV and more)
[153,207,208]
Collagen V
Collagen IX ?
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With minor, directed proteolytic modiﬁcation or through damage to
the matrix, sites of increasingly direct and strong cell interaction can
be exposed by ‘pealing’ away layers of the collagen hierarchicalFig. 3. Accessibility of integrin-binding sequences in context of collagen microﬁbril. A) One
(numbers 1–5 are labeled). The Hodge–Petruska scheme describes the D-period structure of c
M1, M2….M5), of length 1D except M5, which has a length of 0.46D. The collagen monomers m
end on end in order, they would form a complete collagen molecule in terms of sequence and
surface in B. Orientation of the microﬁbril relative to the exterior ﬁbril surface is indicated (b
GASGER are integrin- (direct) binding sequences of descending afﬁnity, MMP cleavage/intera
which may also be a DDR2-binding site), von Willebrand's Factor (vWF) (which is partial
(5) which also may promote hemostasis on the ﬁbril surface, small leucine-rich proteoglycan/
theC-terminal telopeptide (in green)whichmay regulate access to themore sensitive cell-inter
from the ﬁbril exterior (opposite point of black arrow in A). The single microﬁbril is light grayw
tive of the relative accessibilities of these ligand-binding sites in the unmodiﬁed ﬁbril surface (structure (Figs. 3–5). It has also been suggested that bending of the mi-
croﬁbril exposes cell-binding sites [128].
In vitro studies have most often been performed using the mono-
meric triple-helical form of the major ﬁbrillar collagens I–III. Using
libraries of overlapping collagen peptides (collagen toolkits), the
GFOGER sequence has been identiﬁed as a major cell-binding site for
collagen-binding integrins [129,130]. Studies using the ﬁbrillar form of
collagens indicate thatα1 andα10 bind poorly to theﬁbrillar form, sug-
gesting that these two integrins interact with higher afﬁnity to the na-
tive collagen ligands that belong to collagen subfamilies such as the
network-forming collagens (collagen IV for α1β1 expressing cells and
collagen VI for the cartilage integrin α10β1) or the FACIT collagens
(collagen IX forα10β1) [131,132]. In vivo [133], the interaction between
integrinα1β1 and collagen IV occurs on some epithelial, smoothmuscle
and endothelial cells in contact with basementmembranes. Based on li-
gand afﬁnity studies in vitro,α1β1 expressed onmesenchymal cells like
ﬁbroblasts, wouldmainly bind to immature or reorganizingmonomeric
form of ﬁbrillar collagens. Fibroblasts that are in close vicinity of colla-
gen IV-containing basement membranes could possibly access collagen
IV via α1β1. Collagen XIII is another possible ligand for α1β1 [131] and
recent studies have suggested a role for the α1β1-mediated binding to
collagen XVIII during liver injury [133].
4.2. Availability of ﬁbrillar collagens to integrin binding
The ﬁbrillar collagens are themost abundant members of the super-
family. Although each shares signiﬁcant similarity (D-period, triple-D-period of the type I collagen microﬁbril, composed of 5 molecular collagen segments
ollagen packing by dividing the collagen molecule into 5 units (collagen monomers 1–5:
arked M1–M5 are segments of neighboring collagen monomers but if they were stacked
structure [138]. It is shown outside of the collagen ﬁbril in A and within the collagen ﬁbril
lack arrow). Functional sequences are marked with patches of color: GFOGER, GMOGER,
ction domain (in common with the ﬁbronectin-binding domain, the C-terminal region of
ly in common with a major DDR2-binding site), the imino rich repeat sequence, GPO
protein (sLRRP-PG) high afﬁnity binding sequences in the e and d microscopy bands, and
action sites including theMMP cleavage site. B) Part of themicroﬁbrillar D-period is viewed
hile the sequences colored in A are shown as before. This perspective gives some prospec-
see Fig. 2).
Fig. 4. Relative accessibilities to binding sequences and functional domains in the native and ‘functionalized’ (bent or proteolyzed)ﬁbril. A) Key functional domains of collagen aremarked
on the four microﬁbrils modeling the ﬁbril surface, viewed from the ﬁbril's exterior. A qualitative molecular ‘accessibility’ ranking of binding sites was determined for the intact and fol-
lowing MMP cleavage and removal of Monomer 4 from a single microﬁbril. B) View of accessibility of vWF/DDR2-binding site following removal of the ¼ segment from MMP cleavage
(partial Monomer 4 and all of Monomer 5), right and bottom. The DDR2/ﬁbronectin site might facilitate the removal to then expose vWF/DDR2 in the gap region and GMOGER at the
overlap/gap interface. Removal of the remaining collagen fragment, especially the remaining part of Monomer 4, gives clear access to the high-afﬁnity integrin-binding site, GFOGER. Ab-
breviations are as Fig. 3 legend, except for: Glycoprotein VI (GPVI), which binds to imino acid repeat sequences such as GPO5 and C-telopeptide (C-telo).
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subtly distinct in their basic structure from ligand-binding sequences to
their molecular packing and ﬁbrillar structures, leading to different
properties and therefore emphasis and roles within tissues [127,134].
It is believed that the ﬁbrillar collagens form microﬁbrils with a rope-
like assembly of collagen triple-helices and that these microﬁbrils con-
centrically assemble to form ﬁbrils. Well-deﬁned structures for the mi-
croﬁbril and the ﬁbril surface for type I collagen have been obtained
[135,136]. The microﬁbrils are bound within the ﬁbrils by lysyl
crosslinks between the telopeptides and key triple-helical sites on
neighboring D-staggered (where D = 67 nm in hydrated native tis-
sues) as well as extensive side–side packing interactions including
water and protein based hydrogen bonding, electrostatic and hydro-
phobic interactions. Fibrils are decorated with PGs to construct much
larger ﬁbers, which may be capable of fusing and certainly are found
to enable the construction of a variety of variations of a theme in
terms of collagen ﬁber organization [137]. The ﬁber organization varies
from long parallel arrays in tendons to the felt-work like organization
found in dermis. Fig. 3 shows how this ﬁbrillar organization effects the
hierarchically available cell interaction and matrix-binding sites. Thepart of the ﬁbril surface most exposed to the extracellular environment
is the most densely packed, the C-telopeptide region of the D-period
[138]. As such, and due to the presence of immino rich regions in the
C-terminal sequence of the monomer, it may act to stabilize this exposed
region.Underneath this protective layer of collagenmonomers are several
key amino acid sequences that are involved inﬁbril assembly and stability
[139,140] (Figs. 3–5). One of these sequences, GPO5 [137] is the one
known to bind the platelet glycoprotein VI [140] and is found clearly ex-
posed on theﬁbril surface (Figs. 3–4) as are the putative SLRP core protein
interaction sites in the microscopy D and E band regions on Monomer 4
(M4) [22,141]. Due to the large area that the PG covers of the ﬁbril-
bundle, it is likely that they exclude the binding of other ECM ligands in
this region when present. Due to their key role in conveying structural
continuity in most connective tissues, this seems likely to be the case in
most mature connective tissues. This in turn suggests that the majority
of the ﬁbril surface in the mature form is structural, unless it undergoes
some interaction with cells. Limited proteolysis or cell associated torsion
and bending will expose key binding sites in the ﬁbril [128,136].
Themolecular packing of the collagenmonomers in the organization
of the type I ﬁbril and as far as can be inferred due to their smaller size,
Fig. 5.Unmasking of integrin-binding sites during partial proteolysis of collagenmicroﬁbril. A) Viewof the unmodiﬁed surface of amature ﬁbril, 3microﬁbrils shown. B) Viewof a partially
proteolyzedmicroﬁbril. The docked positions of the integrin I domain are shown for the GFOGER and GMOGER sites. The Monomer 5 andMonomer 4 molecular segments obscure these
binding sites, as does Monomer 4 for DDR2 and Monomer 5 for ﬁbronectin. Removal of the C-terminal telopeptide gives partial access to the ﬁbronectin site. Removal of the ¼ segment
(most of Monomer 4 and all of Monomer 5) gives clear access to GMOGER, ﬁbronectin and DDR2. Removal of another small portion ofwhat remains of Monomer 4 opens the GFOGER site
for unrestricted binding also. Abbreviations are as for Fig. 3.
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binding interaction sites are freely available at the ﬁbril surface. In the
simplest of terms, this translates to theMonomer 5 (M5) andM4molec-
ular segments obscuring the principal integrin-binding sites (GFOGER)
as does M4 for DDR2 andM5 for FN-binding site. Removal (or absence)
of the C-terminal telopeptide gives partial access to the FN site. Removal
of the ¼ segment of collagenase cleavage (most of M4 and all of M5
monomers) gives clear access to GMOGER, FN and DDR2. Removal of
yet another small portion of what remains of M4 opens the GFOGER
site for unrestricted binding.
A possible exception to the burying of integrin-binding sequences is
the GASGER sequence (Figs. 3 and 4). However, it is weak binding and
its accessibility may be signiﬁcantly modulated by ﬁbril-associated
PGs or mineralization [142].
Lastly, all of these above mentioned sites are relatively available for
interaction in individual microﬁbrils, for instance, those at the edge of
a region of ﬁbril construction during ﬁber polymerization. That being
said, starting with weak integrin interaction/indirect integrin interac-
tion sites being the most accessible, leading to the strongest direct
integrin collagen-binding sites being the most inaccessible (before the
removal of M4). This could suggest a possible process of progressively
stronger COLINBRI-dependent cellular interaction with mature ﬁbril
modiﬁcations. In the case of tissue repair, the damaged ﬁbrils at these
sites close to the ﬁbril surfacewould be quickly recognized and adhered
to by cells,which could be part of the process of damage sensing and the
repair response. Other than the observations made from the molecular
structure of the ﬁbril surface, there are no direct studies to support
this theoretically based hypothesis, but there are some observations
that could ﬁt with it.
4.2.1. Observations supporting interactions of collagen-binding integrins
with immature collagen matrices
Integrinα11β1 is highly expressed in themouse incisor periodontal
ligament [10,125,143], which is the tissue in the vertebrates with thehighest turnover of collagen I. It is possible thatα11β1 in the periodon-
tal ligament is an organizer of collagen assembly.
α10 expression includes growing epiphyseal cartilage, the ossiﬁca-
tion groove of Ranvier and the meniscus [125,144–146], all sites with
dynamic collagen turnover, suggesting thatα10β1might be an organiz-
er of cartilage collagens.
Collagen V seems to play a central role in cell-assisted collagen
ﬁbrillogenesis [147–149]. The molecular composition of the nucleating
complex at the cell surface has not been characterized yet. If collagen-
binding integrins take part in this process theywouldmostly bind to im-
mature collagen protoﬁbrils to nucleate ﬁbrillogenesis [150].4.2.2. Observation supporting interactions of collagen-binding integrins
with mature collagen ﬁbrils
Bothα2 andα11 I domains bind to collagen Iﬁbrilswithmeasurable
afﬁnity in vitro [132]. Furthermore, integrin antibodies can inhibit cell-
and platelet-binding to ﬁbrillar collagen I.
Intriguingly, structural modeling shows directive restraint in the
docking of integrins (and other ECM ligands) to the binding of collagen
ﬁbrils (see Figs. 4 and 5 as illustration of the point). However, ‘opportu-
nistic’ binding to areas of the ﬁbril surfacemore loosely organized (such
as at bends induced by cell action or damage) and/or directed proteoly-
sis readily and straight-forwardly opens the collagen ﬁbril surface to
strong integrin binding (Fig. 4). The nature of the hierarchical organiza-
tion and the placement of cell interaction sites within it might hint at a
directive process for increasingly strong cell adhesion culminating in
the high-afﬁnity cell-binding site GFOGER. This site itself being located
within the densely packed overlap zonewithin themiddle of themicro-
ﬁbril (and hence somewhat harbored) while the less strong and more
indirect interaction sites are located within the overlap zone (DDR2)
and at the overlap/gap interface (e.g. GMOGER, FN-binding sites) and
are much closer to the ﬁbril surface. Under these conditions integrins
are able to directly interact with collagen ﬁbrils.
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restrained ﬁbrillar collagen matrices in vitro [151–153]. These ﬁbrillar
matrices have formed by self-assembly and are different from the ma-
ture ﬁbrillar matrices seen in vivo. MMPs facilitate collagen reorganiza-
tion in vitro and this process can also occur independently of MMPs,
although less efﬁciently [154,155]. With time, COLINBRIs will be secret-
ed in these matrices and also contribute to the reorganization. One
could argue that the polymerized collagen used in vitro to study the col-
lagen reorganization, in the collagen gel contraction model, contains
monomeric collagen molecules that would coat the collagen ﬁbrils,
but most likely this cannot account for the majority of the rapid and
robust collagen remodeling that occurs in these matrices.
In summary, it is likely that collagen-binding integrins can bind to
both monomeric and ﬁbrillar forms of collagen in physiological settings.
Wepostulate that in assemblingmatrices (development, high tissue turn-
over and regeneration) the availability of integrin-binding sites is high. In
situations where integrins are in contact with mature, highly crosslinked
complex collagen matrices, current structural data indicates that the
availability of direct integrin-binding sites might be a limiting factor and
instead the availability of DDR2-binding site or indirect COLINBRI-
binding sites would be much higher. DDR1 has been reported to regulate
integrin-mediated interactionswith collagen [14] and can cooperatewith
integrins in collagen I-mediated EMT [156]. In contrast, Zhang et al.
recently showed that DDR2, independently of integrins, sustain the EMT
phenotype and facilitate breast cancer invasion [157]. It is possible that
at this early stage, before reorganization of collagen at the tumor bound-
ary, in accordance with the hierarchical availability of collagen receptor
binding sites, DDR2 would be the ﬁrst receptor to bind to the collagen ﬁ-
brils. The DDR2-mediated collagen remodeling would then give access to
the integrin-binding sites and allow cancer cell invasion to occur more
efﬁciently.5. Collaborative role of integrins in ﬁbrillogenesis
We predict that the roles of collagen-binding integrins in collagen
ﬁbrillogenesis will be re-evaluated in the years to come. Whereas sub-
stantial data has been produced on the role ofα5β1 andαvβ3 integrins
in FN assembly [158–160], much less effort has been put into analyzing
the role of collagen-binding integrins.5.1. Fibronectin matrix assembly—a cell driven process
Seminal papers on the role of integrins in FN assembly have demon-
strated a preferred role for α5β1 over αvβ3 in mesenchymal cells [53].
Under artiﬁcial conditions where α5β1 is ablated, small FN ﬁbrils can
form in an αvβ3-dependent manner. Surprisingly, when the RGD
motif of FN is mutated in vivo to become non-functional, αvβ3 can res-
cue assembly by binding to a distinct site [159]. In platelets the αIIbβ3
integrin can take part in FN matrix assembly during thrombus forma-
tion [161]. Separate experiments have demonstrated that also α4β1
[162] and α9β1 [163] can take part in RGD-independent FN assembly
in specialized cells. Part of the increased effectiveness of α5β1 over
αvβ3 in assembling FN matrices has been demonstrated to be due to
enhanced capacity to activate Rho mediated contractility and signaling
by α5β1 [164]. In this context it is interesting to note that in some
cells there is a cross-talk between integrins so that high β1 levels lead
to lower β3 integrin levels due to mRNA destabilization [165]. In a
recent report, knockdown of β1 integrins in malignant mammary epi-
thelial cells elicited a robust compensatory expression of β3 integrins,
but not in their normal counterparts, suggesting that in this system
the cross-talk is correlated with the malignant phenotype [166]. The
cell type speciﬁc integrin cross-talk can thus inﬂuence integrin levels,
and the data also suggests that integrin signalingmight affect other im-
portant factors involved in FN assembly.5.2. Spontaneous assembly and cell-driven collagen ﬁbrillogenesis
Multiple studies have suggested that FN assembly drives collagen
ﬁbrillogenesis, which can be regarded as the dogma in this ﬁeld
(reviewed in [150]). Whereas cell driven assembly is a prerequisite for
FN assembly, collagens under appropriate conditions can form an im-
perfect ﬁbrillar matrix, by self-assembly. Several elegant experiments
have shown that collagen containing telopeptides contribute to a
more homogenous 3D ﬁbrillar structure under some conditions [167].
The telopeptides are not just vital for stabilizing crosslink formation,
the C-telopeptide in particular may regulate access to key ligand-
binding sites (MMP cleavage, FN binding, GFOGER and GMOGER)
(Figs. 3 and 4). Hence the presence of the telopeptides represents key
elements in the assembly (or disassembly) of collagen ﬁbrils.
It is becoming increasingly clear that collagen ﬁbrillogenesis in vivo
needs to be organized and that it occurs at cell surface [150]. For colla-
gen ﬁbrillogenesis in vivo, collagens V and XI, seem to have a nucleating
function for assembly that starts at the cell surface [149]. Convincing
data shows that mice lacking collagen V have severely disturbed colla-
gen I ﬁbrillogenesis [147,168]. Since collagens form complex ﬁbrils, as-
sembled from multiple collagens into heterotypic ﬁbrils coated with
FACIT collagens at the ﬁbril surface, collagen ﬁbrillogenesis is more
complex than the FN type of matrix assembly. Molecules involved in
ﬁbrillogenesis include tenascin-X, TSP-2, SLRPs and COMP at later stages
of the assembly (reviewed in [150]). PN can increase the stiffness of col-
lagen matrices, suggested to occur via increased collagen crosslinking,
but an effect of PN on enhanced ﬁbrillogenesis has not been excluded
[17].
Whereas a number of studies suggest that the collagens are assem-
bled on top of FN networks [160], other studies suggest that collagen
receptors enhance collagen assembly [169] and others have shown
that FN assembly is dependent on a preformed collagen matrix
[147,170]. Especially compelling are studies using human and mouse
ﬁbroblasts isolated from Ehlers–Danlos patients lacking collagen V,
showing that theseﬁbroblasts failed to assemble collagen and FNmatri-
ces [171,172]. Collagen mutations have additional effects such as
changed synthesis of the ECM components, which complicate the pic-
ture further.
The conclusion we draw from these studies is that FN assembly and
collagen ﬁbrillogenesis are tightly connected.When studying these pro-
cesses at the cell level it seems essential to ﬁrst of all characterize the
cell repertoire of FN and collagen receptors. We postulate that in cells
with high levels of FN receptors like α5β1 (strongly promoting FN
assembly), and that at the same time express low levels of collagen re-
ceptors, will be prone to assemble an extensive FN matrix, which will
guide collagen ﬁbrillogenesis. Conversely, in cells that express high
levels either of the collagen receptors α2β1 or α11β1 combined with
low expression levels of FN receptors, we suggest that integrins will
primarily nucleate collagen ﬁbrillogenesis and incorporate FN onto
these collagen ﬁbrils, in a manner dependent on the availability of the
FN-binding sites.
Studies performed in vitro present a number of limitations that are
important to remember when interpreting the results in the context
of our current knowledge about the assembly process of FN. For exam-
ple, when using GD-25 -β1 cells, which are embryonic cells of unknown
origin that lack collagen receptors, it is quite possible that some intra-or
extracellular factors related to collagen receptor functions are alsomiss-
ing [169]. When these cells are transfected with cDNA encoding either
α2 or α11 integrin chain, it is thus possible that FN-mediated assembly
of collagens is favored over collagen receptor-mediated assembly, con-
tributing to a biased view of how the assembly process occurs [169].
Most published studies on integrin-mediated collagen ﬁbrillogenesis
have been performed without considering the more recently identiﬁed
collagen receptors α10β1 [173] and α11β1 [174]. However, since
α10β1 is mainly expressed on chondrocytes and seems to prefer non-
ﬁbrillar collagens, we predict that themajor collagen receptors involved
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is more widely expressed than α11β1, which is restricted to subsets
of ﬁbroblasts [10,143,153]. More systematic studies on the relative
importance of these integrins for collagen ﬁbrillogenesis together
with studies addressing whether these receptors show different
abilities to nucleate and direct collagen ﬁbrillogenesis remain to
be performed.
In summary: Compared to FN assembly, collagen assembly is more
complex. At the cell surface level, fewer integrin types might be able
to directly nucleate collagen ﬁbrillogenesis compared to FN assembly,
but the subsequent collagen ﬁbrillogenesis steps contain more compo-
nents, which all can vary in a cell speciﬁc manner.
For future studies of FN and collagen ﬁbrillogenesis, it will be essen-
tial to characterize FN and collagen receptor repertoires, as well as the
isoforms of small Rho GTPases and their regulators present in cells
and shown to be involved in collagen remodeling [175–177]. Only
then can one begin to understand the molecular mechanism of matrix
assembly in the context of different mesenchymal cell types such as
osteoblasts, chondrocytes and ﬁbroblasts.
6. Lack of expected phenotypes in mouse models: role of
collagen-binding integrins?
6.1. Limitations of mouse as animal model
The phenotypes observed in mice with defects in the collagen-
binding integrins are summarized in Table 2. The broadly expressed
α1β1 and α2β1 integrins have been studied extensively, whereas sub-
stantially less has been published on the collagen-binding integrins
α10β1 and α11β1. Interestingly both α10β1 and α11β1 show a re-
markable cell speciﬁcity in their cell expression pattern in the tissues.
During normal development α10β1 is restricted to chondrocytes and
a subset of junctional ﬁbroblasts [144,146].α11β1 is restricted to ﬁbro-
blasts in dense connective tissues but display a transitory expression in
odontoblasts [10,143]. From in vitro studies, α11 has been shown to be
induced upon cell culture of mesenchymally-derived cells not normally
expressingα11 in vivo (chondrocytes, myoblasts, and endothelial cells)
([178], unpublished data). Cultured mesenchymal stem cells also ex-
press high levels of α11 [179]. Since collagen is themost abundant pro-
tein family in vertebrates, and multiple disease-causing mutations in
collagens have been described (Table 3), one would also expect severe
defects when individual or multiple collagen receptors are lacking.
Whereas mutations in ﬁbrillar collagens have revealed severe defects
in the bone, cartilage, skin, tendon, blood vessels, an analysis of
collagen-binding integrins at this stage does not reveal the correspond-
ing phenotypes, with one exception, the α10 integrin cartilage pheno-
type (Table 3).
This is unlike the situation for some other integrin–ligand pairs, like
integrins–laminins, integrins–FN [180], where mutations of integrins
give rise to similar phenotypes as mutations of ligands and hence con-
ﬁrm a major contribution of integrins to the integrated biological func-
tion of these ligands. The reason for this lack of correlation between
integrin and ligand phenotypes can be manifold in the case of ﬁbrillar
collagens:
1. The structural defects seen when collagen is lacking or mutated,
might not primarily be dependent on the interaction with cells.
Fibrillar collagens more than any other ECM protein form the arma-
ment that reinforces the basic ECM structure.
2. In addition to direct linkages to collagen, indirect linkages mediated
via COLINBRIs contribute to attaching cells to the ECM network
under normal conditions. The ﬁbrillar collagen phenotypes would
in some instances be reﬂected in the phenotypes from several
integrins, some of which will include COLINBRI-binding integrins.
3. Mild phenotype in genetic models could be due to integrins having
overlapping roles. Further analysis when multiple collagen-bindingintegrins are inactivated in advanced compound mouse models will
reveal whether they act together and have overlapping roles.
4. In genetic models, compensation mechanisms by other collagen-
binding integrins, COLINBRI-binding integrins or both collagen-
binding and COLINBRI-binding integrins might compensate for loss
of collagen-binding integrins, whichwould explain themild, restrict-
ed phenotypes observed when individual integrins are inactivated.
5. Finally, using small animals the existing data so far for individual
knockouts suggest that collagen-binding integrins have a limited
role during embryonic development and in normal adult tissue ho-
meostasis. One recent unexpected recent ﬁnding in dogs, suggests
that cartilage might be the ﬁrst tissue where a collagen phenotype
corresponds to a collagen-binding integrin mutant phenotype
(Table 3). Dogs with mutations in α10 integrin develop a severe
canine chondrodysplasia [181], whereas α10 mutations in mice
only lead to very mild cartilage phenotype [146]. A number of muta-
tions inmouse show important differentmanifestations compared to
corresponding mutations in humans [182]. The different physiology
of small rodents and an upright-walking human is expected to
result in differences in phenotypic manifestations, especially in the
muscoskeletal system. Since several collagens are present in the car-
tilage matrix it is unclear what the in vivo ligand(s) for α10β1 are,
but analysis of collagen deﬁcient mouse phenotypes would suggest
that collagen II and collagen XI are likely candidates.
Interestingly, the DDR-deﬁcient mice have more severe phenotypes
than any of the collagen-binding integrin deﬁcient mice, indicating a
role of these cell surface proteins during development [183,184]. It is
however unclear if these phenotypes in DDR−/−mice reﬂect defective
cell–collagen linkages or if the observed defects are related to the indi-
rect effect of impaired cell signaling originating from these enigmatic
tyrosine kinase receptors. DDR2mutation in human also leads to a skel-
etal disorder, a rare form called pondylo-meta-epiphyseal dysplasia
[185].
In summary: Although we do not fully understand the role of
collagen-binding integrins, in our current understanding they have lim-
ited roles during embryonic development and in normal adult tissue
homeostasis. The ﬁnding that integrin α10-deﬁciency causes a severe
skeletal phenotype when analyzed in larger animals suggests that also
for the other collagen-binding integrins, the mouse phenotype might
not reﬂect the role of these receptors in larger mammals, where muta-
tions in cells forming the skeleton manifest a more severe phenotype.
We believe that COLINBRIs serve as an important link in vivo to ma-
ture crosslinked collagen ﬁbrils and offer one explanation to why the
phenotypes of the ligand – receptor pair collagen – collagen receptors
do not correlate to the same degree as for other ligand–integrin pairs.
However, to resolve these issues, more complex compound integrin
deﬁcient mouse models are needed.
6.2. Integrin type collagen receptors in pathology
Challenging of theα1 andα2 deﬁcientmousemodels have revealed
phenotypes in inﬂammatory conditions, wound healing, tumor metas-
tasis and bone physiology (Table 3). Similar studies in the α10 and
α11-deﬁcient mouse models remain to be performed.
In a recent review article the role of collagen-binding integrins are
discussed in the context of stem cells/stem cells niche in skeletalmuscle
and adipose tissue in connectionwith obesity [186]. The background for
these suggestions goes back to the ﬁnding that the stiffness of the ma-
trix seems to direct stem cell fate [187]. Volloch and Olsen [186] tried
to relate the fate of stem cells in fat and muscle tissues to the type and
number of collagen-binding sites for α1β1/α2β1 (native collagens I
and IV) and αvβ3 (denatured collagens I and IV). It is suggested that a
distinct α1β1 integrin-binding site present in the non-collagenous do-
main of collagen IV determines adipogenic cell fate and prevents stem
cells in fat tissue to differentiate along a non-adipogenic pathway
Table 2
Phenotypes of mice deﬁcient in collagen-binding integrins.
Integrin
subunit
Distribution Knockout phenotype Phenotype of challenged knockout mice
α1 Endothelial cells, smooth muscle cells, ﬁbroblasts and
more cell types [209]
Normal development [209], hypocellular
dermis [210,202], isolated cells display
defect in collagen IV cell attachment
Reduced inﬂammation [211], reduced psoriasis [212],
prevention of contact hypersensitivity [213], reduced
tumor vascularization [214], reduced bone fracture healing
[215], exacerbated diabetes-induced kidney disease [216],
accelerated age-dependent osteoarthritis [217]
α2 Platelets, epithelial cells, endothelial cells [218],
mesenchymal stem cells [179], ﬁbroblasts and
more cell types
Mild mammary gland phenotype, otherwise
normal development [219,220], cell
attachment
defect to collagen I of isolated platelets [221],
needed for thrombus stabilization [222]
Defective inﬂammatory response to listeria infection [223],
augmented vascularization in wound healing [200,224],
improvedbonedensity agingmice [225], reduced inﬂammation
and cartilage destruction in rheumatoid arthritis model [226],
reduced glomerular injury [227], increased tumor metastasis
[228]
α10 Chondrocytes and subsets of junctional ﬁbroblasts
[144,173].
Mild cartilage phenotype [222] NDa
α11 Subsets of ﬁbroblasts[143,153,174], cancer associated
ﬁbroblasts [229], increased levels onmyoﬁbroblasts [230],
developmental expression in odontoblasts, mesenchymal
stem cells [179], induced in cultures of mesenchymally-
derived cells including myoblasts (do not express α11
in vivo) [178]
Defective incisor eruption [10], dwarﬁsm
[231],
increased mortality
ND
a Not determined.
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review is interesting, but similar comparison should include an analysis
of possible α11β1 integrin involvement, and experimental approaches
to support the suggestion that type and availability of integrin-
dependent collagen-binding sites determine stem cell differentiation
should be undertaken.
To understand the gene function in the context of human physiology
it will also be interesting in the years to come to analyze the effect of
integrin mutations in rare human genetic disorders. Gene linkage anal-
ysis, single-nucleotide polymorphism analysis and gene network analy-
sis have been used so far in studies implying collagen-binding integrins
in disease. A limited study has indicated roles for ITGA1 polymorphisms
in predisposing Korean women to osteoporosis [188]. Numerous re-
ports have implicated platelet ITGA2 expression in the control of hemo-
stasis [189,190]. The oldest report of integrin α2 function in platelets
refers to one patient with a bleeding disorder and lack of GPIa [191].Table 3
Comparison of phenotypes in mice deﬁcient in collagens or collagen-binding integrins.
Ligand
Fibrillar
collagen
KO phenotype in mouse KO phenotype in hum
I Mov13 mice [232]: embryonic lethality E12-14,
major blood vessel rupture
EDSa VIIA, EDS VIIB, O
osteoporosis, joint
hypermobility
II Perinatal lethality [233,234] short long bones,
rudimentary vertebral arches, lack of inter-vertebral
discs, notochord defect
Lethal achondrogenes
osteochondrodysplasi
osteoarthrosis
III Neonatal lethality [235], 5% survival with shorter lifespan,
intestinal defect, skin lesions, arterial rupture
EDS IV, arterial aneury
V Embryonic lethality E10–11 [147], cardiovascular
insufﬁciency, lack of collagen ﬁbrillogenesis
EDS I, EDS II
XI Cho mice: perinatal lethality by asphyxia [236], weak
tracheal cartilage, short snout and mandible, cleft palate,
short limbs, externally rotated distal portion of hindlimbs
Schmid chondrodyspl
non-syndromic hearin
loss, osteoarthrosis
XXIV ? ?
XXVII Mutant transgene[237]: perinatal lethality, lung defect,
chondrodysplasia
?
a Ehlers–Danlos syndrome.
b Osteogenesis imperfecta.The role of α2β1 in human platelets might thus be different from its
role in mouse platelets. More recent studies suggest ITGA2 polymor-
phism as a predisposing factor in stroke and myocardial infarction
[192–195].
The recent identiﬁcation of ITGA10mutation as the causative muta-
tion in severe canine chondrodysplasia [181] suggests that human
ITGA10 mutations might also have more severe phenotypes than the
mild cartilage phenotype seen in Itga10 deﬁcient mice [146]. Finally,
analysis of susceptibility modules for coronary artery disease using a
genome wide integrated network analysis approach suggests that
ITGA11might be involved in vascular disease [196]. Since α11 expres-
sion to our knowledge is restricted to ﬁbroblasts, the possible involve-
ment of α11 in cardiovascular disease will be interesting to follow up.
With the advancement ofwhole genome sequencingwe are likely to
obtain a clearer picture of the role of collagen-binding integrins in
human disease in the years to come.Receptor
an Putative
collagen
receptor(s)
in vivo
Correlation KO phenotypes
collagen/receptor in mouse
KO phenotype in human/dog
Ib, α2β1
α11β1
Not in single integrin mutant strains ?
is II,
a,
α1β1
α2β1
α10β1
α10 integrin mutation [146], mild
cartilage defect
β1 integrin [197], severe cartilage
defect
Chondrodysplasia in dogs,
integrin α10 mutation [181],
severe cartilage phenotype
sms α2β1
α11β1
? ?
α2β1
α11β1
? ?
asia,
g
α2β1
α10β1
α11β1
α10 integrin mutation [146], mild
cartilage defect
β1 integrin [197], severe cartilage
defect
Chondrodysplasia in dogs,
integrin α10 mutation [181],
severe cartilage phenotype
? ?
α2β1
α11β1
? ?
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of COLINBRIs?
In tissues like the periodontal ligament with high collagen turnover,
the direct collagen interaction appears to be essential (supported by
knockout phenotype of α11 integrin deﬁcient mouse [10,125]), but
the absence of the COLINBRI molecule PN in the periodontal ligament
likewise leads to a severe phenotype [86], supporting an important
role of both direct and indirect linkingmechanismof cells toﬁbrillar col-
lagens in the periodontal ligament (Fig. 6).
Conditional deletion of β1 integrins in the cartilage has indicated an
important role of integrins for chondrogenesis [197] and probably also
collagen II assembly, but individual integrin α-chain phenotypes have
so far failed to replicate the β1 integrin deﬁcient phenotype inmice. Car-
tilage might thus be another example where collagen-binding and
COLINBRI-binding integrins cooperate during embryogenesis (Fig. 6).
In vitro experiments have suggested distinct roles of α5β1 and αv-
containing integrins on endothelial cells during angiogenesis [54],
whereas in vivo, compound αv/α5 deﬁcient mice do surprisingly wellFig. 6. Schematic illustration of some biological processes where direct and indirect binding t
mechanisms in biological processes is predicted from phenotype data obtained with integrin k
wound and contract the granulation tissue. We suggest a cooperation between indirect and
tooth eruption, both direct and indirect cell-collagen interaction could play an essential role
also predict collaboration between collagen- and COLINBRI-binding integrins in chondrogen
ﬁbronectin-rich environment. Angiogenesis is supported both by the “ﬁbronectin, vitronectin aup till midgestation, unlikemice deﬁcient in β1 integrins on endothelial
cells [198,199]. Independent studies have implied collagen receptors in
angiogenesis [200,201]. This suggests the involvement of other FN-or
collagen receptors on endothelial cells that possibly in a COLINBRI-
mediated mechanism could contribute to angiogenesis (Fig. 6).
During wound healing integrin on dermal ﬁbroblasts are thought to
mediate collagen reorganization to close the wound and contract the
granulation tissue. In this process also, mice defective in individual col-
lagen receptors [200,202,203] have failed to reproduce the phenotype
in β1 integrin-defective mice [204], suggesting a cooperation between
indirect and directmechanisms for cellular interactions with the granu-
lation tissue collagen.
In pathological situations with high turnover of both FN and colla-
gens the chances for both mechanisms of cell adhesion are high. We
predict parallel roles of collagen-binding and COLINBRI-binding
integrins in wound healing and ﬁbrosis. In this context the changed
stiffness of the contracting collagen matrix might be sensed by
COLINBRI-binding integrins, which in turn could contribute to TGF-β
activation.o collagen cooperate. The cooperation between direct and indirect cell-collagen-binding
nockout mice. During wound healing, dermal ﬁbroblasts reorganize collagen to close the
direct mechanisms for cellular interactions with the granulation tissue collagen. During
as supported by knockout phenotypes of α11 integrin- and periostin-deﬁcient mice. We
esis, where mesenchymal cells differentiate to chondrocytes in a ﬁbrillar collagen- and
nd periostin”-COLINBRI-binding integrin and collagen receptors.
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We have tried to highlight some recent dilemmas in the collagen-
binding integrin ﬁeld. Whereas collagens are the major building blocks
in tissues and defects in these structural proteins have severe conse-
quences for tissue integrity, the mild phenotypes of the integrin type
of collagen receptors have raised questions about their importance in
tissue biology and pathology. We have tried to offer some explanations
for the observations obtained so far, including the suggestion that indi-
rect mechanisms for anchoring cells into collagen ﬁbrils exist in parallel
with direct collagen binding. We furthermore suggest that mutations in
integrins, expressed in the muscoskeletal system, are biased towards a
mild phenotype in mice but will be more strongly manifested in larger
vertebrates. We thus offer alternative interpretations for the observed
mild phenotypes, and if proven correct in the analyses of new com-
pound mouse models and genetic diseases in larger animals/humans,
we believe that the collagen-binding integrins will come into the lime-
light of connective tissue biology.Acknowledgements
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